Corporate Investor

Updated:

Aier Ophthalmology

Aier Ophthalmology began in 2003 under Chen Bang. The firm operates as a corporate investor tied to its hospital business rather than a traditional family...

Aier Ophthalmology logo

Aier Ophthalmology

Aier Ophthalmology began in 2003 under Chen Bang. The firm operates as a corporate investor tied to its hospital business rather than a traditional family office. The group deploys capital into its own facilities and selected external projects. Confirmed holdings include the New Century Mansion commercial property in Changsha and a hospital network spanning China, the United States, Spain, Singapore and the United Kingdom. It maintains partnerships with Orbis International for blindness prevention and with Central South University through the Aier School of Ophthalmology. Asset classes include direct real estate and healthcare operating companies. The listed entity on the Shenzhen Stock Exchange provides the primary capital base. Additional offices support the international hospital footprint. Philanthropic arms consist of the Aier Ophthalmology Charity Foundation and the Hunan Eye Care Foundation. No operational events from the last 24 months appear in available records. The firm maintains membership in the World Association of Eye Hospitals and collaborates with the International Association of Contact Lens Educators on training programs. These ties supply sector-specific sourcing channels distinct from standard private-equity networks.

General information

Firm type

Corporate Investor

Year founded

2003

Location

Region

Asia

Country

China

City

Changsha

Corporate office

Changsha, China

Additional offices

USA · Spain · Singapore · UK

Principals

Chen Bang

Chairman

Li Li

CEO

Sector focus

Healthcare Services

Frequently asked questions

Who runs investment decisions at Aier Ophthalmology?

Chen Bang serves as chairman and ultimate controller. Li Li acts as CEO and holds a significant minority stake.

Does Aier Ophthalmology participate in fund commitments or only direct deals?

Available records show direct ownership of operating hospitals and one commercial property. No fund commitments are disclosed.

Where does the underlying wealth come from?

The capital base originates from the Shenzhen-listed Aier Eye Hospital Group and its affiliated medical investment entity.

Does Aier Ophthalmology maintain philanthropic structures, and how are they separated?

Two foundations operate alongside the commercial entity: the Aier Ophthalmology Charity Foundation and the Hunan Eye Care Foundation.

What is Aier Ophthalmology's known posture on co-investments alongside external GPs?

No co-investment activity with external managers is recorded in the source material.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Changsha Corporate Investor profiles